Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:00557'
s PB Ratio Range Over the Past 10 Years
Min: 0.53 Med: 1.56 Max: 4.2
Current: 1.36
During the past 13 years, China Tian Yuan Healthcare Group's highest PB Ratio was 4.20. The lowest was 0.53. And the median was 1.56.
HKSE:00557's PB Ratio is ranked worse than 60.72% of 527
companies
in the Credit Services industry
Industry Median: 1.06
vs HKSE:00557: 1.36
During the past 12 months, China Tian Yuan Healthcare Group's average Book Value Per Share Growth Rate was -17.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -10.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -9.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -11.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of China Tian Yuan Healthcare Group was 4.80% per year. The lowest was -18.60% per year. And the median was -4.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
China Tian Yuan Healthcare Group PB Ratio Related Terms
China Tian Yuan Healthcare Group PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Credit Services subindustry, China Tian Yuan Healthcare Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Tian Yuan Healthcare Group PB Ratio vs Credit Services Industry
For the Credit Services industry and Financial Services sector, China Tian Yuan Healthcare Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where China Tian Yuan Healthcare Group's PB Ratio falls into.
China Tian Yuan Healthcare Group PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
China Tian Yuan Healthcare Group (HKSE:00557) has a PB Ratio of 1.35 as of Aug. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on China Tian Yuan Healthcare Group and its competitors. This is 13% below median its historical median of 1.56. Over the past decade, China Tian Yuan Healthcare Group's PB Ratio has ranged from 0.53 to 4.20. According to the industry distribution chart, China Tian Yuan Healthcare Group ranks #320 out of 527 companies in the Credit Services industry, placing it in the top 60.7%.
Is China Tian Yuan Healthcare Group's PB Ratio too high?
China Tian Yuan Healthcare Group's current PB Ratio of 1.35 is 13% below median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 4.20. The Credit Services industry median PB Ratio is 1.06. China Tian Yuan Healthcare Group's value of 1.35 is 27.4% above this industry median. Based on the distribution chart, China Tian Yuan Healthcare Group ranks #320 out of 527 companies in the Credit Services industry, which is below the industry midpoint. Overall, China Tian Yuan Healthcare Group has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Tian Yuan Healthcare Group's PB Ratio compare to V and MA?
According to the Credit Services industry distribution chart, China Tian Yuan Healthcare Group ranks #320 out of 527 companies for PB Ratio. This places China Tian Yuan Healthcare Group in the lower half of its industry. The industry median PB Ratio is 1.06. China Tian Yuan Healthcare Group's value of 1.35 is 27.4% above this benchmark. Historically, China Tian Yuan Healthcare Group's own PB Ratio has ranged from 0.53 to 4.20 over the past decade. While the company's 10-year median is 1.56 vs. the industry median of 1.06, China Tian Yuan Healthcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Credit Services company?
The median PB Ratio among Credit Services companies is 1.06, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Tian Yuan Healthcare Group's current PB Ratio of 1.35 is 27.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on China Tian Yuan Healthcare Group and its competitors. For the Credit Services industry, the median PB Ratio is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Tian Yuan Healthcare Group's current PB Ratio is 1.35, which is 13% below median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Tian Yuan Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, China Tian Yuan Healthcare Group (HKSE:00557) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.32, compared to a current price of HK$0.55 — trading 70.3% above its estimated fair value. The current PB Ratio is 1.35, which is 13% below median its 10-year median of 1.56 and 27.4% above the Credit Services industry median of 1.06. China Tian Yuan Healthcare Group's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For China Tian Yuan Healthcare Group (HKSE:00557), the current PB Ratio is 1.35 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Tian Yuan Healthcare Group (HKSE:00557) Overvalued in 2026?
Based on GuruFocus' analysis, China Tian Yuan Healthcare Group stock appears to be overvalued.
The current stock price of HK$0.55 is trading 70.3% above its estimated GF Value™ of HK$0.32.
GuruFocus considers China Tian Yuan Healthcare Group to be Significantly Overvalued.
Key valuation signals for HKSE:00557:
PB Ratio: 1.35 (13% below median its 10-year median of 1.56)
GF Value™: HK$0.32 vs. price of HK$0.55 (70.3% above fair value)
Industry Position: 27.4% above the Credit Services median (#320 of 527)
No single metric tells the full story. See the HKSE:00557 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Tian Yuan Healthcare Group Ltd is an investment holding company engaged in investment holding, provision of procurement, marketing and management services to the medical industry, provision of procurement services relating to the hospitality industry, licensing of trademarks, and money lending and related business. Its segments include Investment Holding, Healthcare, Money Lending and Related Business, which generates maximum revenue from interests earned from the provision of loans to third parties, referral and handling fees for loan-related services, and the introduction of prospective lenders and borrowers in PRC and Hong Kong; and Hospitality. The company generates maximum revenue from Hong Kong.
28GF Score
Get the complete analysis for HKSE:00557
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00557 has been successfully added to your 
